[1] Mori T, Nomori H, Ikeda K, et al.  Diffusion-weighted magnetic reso nance imaging for diagnosing malignant pulmonary nodules/ masses: comparison with positron emission tomography[J]. J Thorac Oncol, 2008, 3(4): 358-364.   doi: 10.1097/JTO.0b013e318168d9ed
[2] Nomori H, Mori T, Ikeda K, et al.  Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer falsepos-itive results[J]. J Thorac Cardiovasc Surg, 2008, 135(4): 816-822.   doi: 10.1016/j.jtcvs.2007.10.035
[3] Kim CK, Park BK, Choi JY, et al.  Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT[J]. JComputAssist Tomogr, 2007, 31(6): 868-875.
[4] Kong G, Jackson C, Koh DM, et al.  The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI[J]. Eur J Nucl Med Mol Imaging, 2008, 35(7): 1323-1329.   doi: 10.1007/s00259-008-0743-z
[5] Squillaci E, Manenti G, Mancino S, et al.  Staging of colon cancer: whole-body MRI vs whole-body PET-CT—initial clinical experience[J]. Abdom Imaging, 2008, 33(6): 676-688.   doi: 10.1007/s00261-007-9347-5
[6] Schmidt GP, Baur-Melnyk A, Haug A, et al.  Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1[J]. 5 and 3T compared to FDG-PET-CT. Eur J Radiol, 2008, 65(1): 47-58.
[7] Seiboth L, Van Nostrand D, Wartofsky L, et al.  Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer[J]. Thyroid, 2008, 18(2): 103-111.   doi: 10.1089/thy.2007.0135
[8] Seemann MD, Meisetschlaeger G, Gaa J, et al.  Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI[J]. Eur J Med Res, 2006, 11(2): 58-65.
[9] Yong TW, Yuan ZZ, Jun Z, et al.  Sensitivity of PET/MR images in liver metastases from colorectal carcinoma[J]. Hell J Nucl Med, 2011, 14(3): 264-268.
[10] Boss A, Bisdas S, Kolb A, et al.  Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT[J]. J Nucl Med, 2010, 51(8): 1198-1205.   doi: 10.2967/jnumed.110.074773
[11] Thorwarth D, Henke G, Muller AC, et al.  Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: firstexperience[J]. IntJRadiatOncolBiolPhys, 2011, 81(1): 277-283.
[12] Pichler BJ, Judenhofer MS, Wehrl HF.  PET/MRI hybrid imaging devices and initial rusults[J]. Eur Radiol, 2008, 13(6): 1077-1086.